 SAN DIEGO, July 29, 2021 GLOBE NEWSWIRE -- Exagen Inc. Nasdaq: XGN, a leading provider of autoimmune testing solutions, today announced its participation in the Canaccord Genuity 41st Annual Growth Conference, which takes place August 10-12, 2021. Ron Rocca, Exagens President and Chief Executive Officer, and Kamal Adawi, Chief Financial Officer, will participate in a virtual fireside chat on Thursday, August 12 at 12:00 PM EST. 